<DOC>
	<DOCNO>NCT00283218</DOCNO>
	<brief_summary>The hypothesis optimal formulation fast act intermediary act insulin analogue improve post prandial glycaemic control patient type 1 diabetes . OBJECTIVE : The objective describe pharmacodynamic ( PD ) pharmacokinetic ( PK ) profile Insulin Aspart ( IAsp ) , Biphasic Insulin Aspart ( BIAsp ) 30 , 50 70 period 12 hour follow standard test meal four day respectively subject type 1 diabetes .</brief_summary>
	<brief_title>A Comparison Pharmacodynamics Pharmacokinetics Insulin Aspart , Biphasic Insulin Aspart 30 , 50 70 .</brief_title>
	<detailed_description>This trial single centre , open-label , randomise 4 period cross-over trial , compare pk pd profile IAsp , BIAsp 30 , BIAsp 50 BIAsp 70 standard test meal subject type 1 diabetes . The profile derive 12-hour period subcutaneous injection abdominal region single dose IAsp , BIAsp 30 , BIAsp 50 BIAsp 70 test meal . The trial consist screen period 4-21 day 4 treatment visit</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>1 . Informed consent obtain trialrelated activity . 2 . Diagnosed type 1 diabetes age 40 insulin treatment within one year diagnosis . 3 . Insulin treatment regime one year time inclusion . 4 . Total insulin demand ≥ 0,5 IU/kg/24 hrs 5 . HbA1c 7 % 12 % ( value include ) . 6 . Age ≥ 18 year . 7 . BMI 18 35 kg /m2 ( include value ) . 1 . Known suspect allergy trial product ( ) relate product . 2 . Recurrent major hypoglycaemic episode . 3 . Heart : Unstable Angina Pectoris , AMI &lt; 12 month heart insufficiency classify accord NYHA IIIIV 4 . Blood Pressure : Severe uncontrolled hypertension BP &gt; 180/110 mmHg , sit 5 . Liver : Impaired hepatic function correspond serumALAT –basic phosphatase &gt; 2x upper reference limit local laboratory . 6 . Kidneys : Impaired renal function correspond serumcreatinin &gt; 150 μmol/l accord local laboratory . 7 . Any disease judge investigator affect trial . 8 . Pregnancy , breast feeding intention become pregnant fertile woman use adequate contraceptive measure – adequate contraceptive method sterilisation , hysterectomy current use contraceptive pill intra uterine device . 9 . The receipt investigational drug within three month period prior trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>